Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.96 USD | +0.34% | +5.29% | -63.94% |
Mar. 27 | JPMorgan Lowers RAPT Therapeutics' Price Target to $13 From $15, Keeps Neutral Rating | MT |
Mar. 18 | RAPT Therapeutics, Inc.(NasdaqGM:RAPT) dropped from S&P Biotechnology Select Industry Index | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 311M |
---|---|---|---|---|---|
Net income 2024 * | -129M | Net income 2025 * | -164M | EV / Sales 2024 * | - |
Net cash position 2024 * | 132M | Net cash position 2025 * | 181M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.86
x | P/E ratio 2025 * |
-2.88
x | Employees | 131 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.47% |
Latest transcript on RAPT Therapeutics, Inc.
1 day | +6.31% | ||
1 week | +2.88% | ||
Current month | +4.20% | ||
1 month | -0.67% | ||
3 months | -64.11% | ||
6 months | -47.47% | ||
Current year | -64.06% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Wong
CEO | Chief Executive Officer | 52 | 15-07-31 |
Rodney Young
DFI | Director of Finance/CFO | 61 | 19-12-01 |
Jim Farmer
CTO | Chief Tech/Sci/R&D Officer | - | 22-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 19-12-03 |
William Rieflin
CHM | Chairman | 64 | 16-03-31 |
Wendye Robbins
BRD | Director/Board Member | 63 | 19-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.02% | 227 M€ | +4.45% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 8.96 | +0.34% | 621 744 |
24-03-27 | 8.93 | +6.31% | 635,425 |
24-03-26 | 8.4 | +1.57% | 571,676 |
24-03-25 | 8.27 | -0.72% | 861,044 |
24-03-22 | 8.33 | -2.12% | 805,278 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.06% | 311M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.86% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |